Per Falholt has entered the board of the Biotek company Cytovac which develops new cancer therapies based on the patient’s own cells, helping the immune system to fight the disease.
Per Falholt has entered the board of the Biotek company Cytovac which develops new cancer therapies based on the patient’s own cells, helping the immune system to fight the disease.